| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.3M | -31.9% | +292.3% |
| SG&A Expense | $1.8M | +41.8% | +108.5% |
| Operating Income | -$3.1M | +1.9% | -158.5% |
| Interest Expense | $111K | +54.2% | — |
| Income Tax | $0 | — | — |
| Net Income | -$3.1M | +3.1% | -175.6% |
| EPS (Diluted) | -$3.97 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $0 | — | -100.0% |
| Current Assets | $1.8M | -18.2% | -63.4% |
| Total Assets | $4.3M | -2.1% | -40.2% |
| Current Liabilities | $4.9M | -14.9% | +597.3% |
| Total Liabilities | $4.9M | -15.0% | +532.3% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.6M | — | — |
| Investing Cash Flow | -$250K | — | — |
| Financing Cash Flow | $5.3M | — | — |
| -1034.3% |
| -$633K |
| +55.0% |
| -110.0% |